PRTT OTC
Protect Pharmaceutical Corporation
1W: +2.4%
1M: -5.6%
3M: +126.7%
YTD: +84.8%
1Y: -28.6%
3Y: -70.7%
5Y: -70.2%
$0.17
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$132M
-2.9% ▼
Gross Profit
$73M
-1.0% ▼
Operating Income
$58M
+21.2% ▲
Net Income
$56M
+22.7% ▲
EPS (Diluted)
$0.98
+22.5% ▲
EBITDA
$58M
+21.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $6M | $79M | $82M | $136M | $132M |
| YoY Growth | +0.0% | +1226.3% | +3.8% | +66.5% | -2.9% |
| Cost of Revenue | $78K | $34M | $40M | $63M | $60M |
| Gross Profit | $6M | $44M | $42M | $73M | $73M |
| Gross Margin | 98.7% | 56.3% | 50.8% | 53.8% | 54.9% |
| R&D Expenses | $0 | $2M | $2M | $5M | $3M |
| SG&A Expenses | $42K | $15M | $15M | $21M | $12M |
| Operating Expenses | $48K | $16M | $16M | $26M | $15M |
| Operating Income | $6M | $28M | $25M | $48M | $58M |
| Operating Margin | 97.9% | 35.4% | 30.9% | 34.9% | 43.6% |
| Interest Expense | $1K | $0 | $0 | $0 | $0 |
| Income Before Tax | $6M | $28M | $25M | $48M | $58M |
| Tax Expense | $0 | $8M | $3M | $2M | $1M |
| Net Income | $6M | $20M | $22M | $46M | $56M |
| Net Margin | 97.8% | 25.6% | 27.4% | 33.7% | 42.6% |
| EPS (Diluted) | $0.11 | $0.36 | $0.43 | $0.80 | $0.98 |
| EBITDA | $6M | $28M | $25M | $48M | $58M |
| Shares Outstanding | 55M | 56M | 53M | 57M | 57M |